tetano
Editor, Senior Moderator
High Blood Press Cardiovasc Prev
. 2021 Apr 27.
doi: 10.1007/s40292-021-00452-y. Online ahead of print.
Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy
Salvatore Greco[SUP] #[/SUP][SUP] 1 [/SUP], Andrea D'Amuri[SUP] #[/SUP][SUP] 1 [/SUP], Enrico Giorgini[SUP] 1 [/SUP], Francesco Luciani[SUP] 1 [/SUP], Mariarosaria Lopreiato[SUP] 1 [/SUP], Valeria Fortunato[SUP] 1 [/SUP], Alessandro Scopa[SUP] 1 [/SUP], Grazia Vestita[SUP] 1 [/SUP], Eleonora Capatti[SUP] 2 [/SUP], Angelina Passaro[SUP] 3 4 [/SUP]
Affiliations
Abstract
Introduction: The outbreak by SARS-CoV-2 has rapidly spread worldwide. The need for specific treatments to adequately stop the inflammatory response and its sequelae is day by day more urgent and many therapeutic strategies were performed since COVID-19 burst in the last months. Statins were thought to be effective against this novel coronavirus for their anti-inflammatory properties, even if the real effects on COVID patients are still partially unexplored.
Methods: We retrospectively evaluated 501 adult patients, consecutively admitted to the two COVID-hospitals of Ferrara's territory, and divided them into two groups: ST = patients on statin therapy on admission and NST=patients not on statin therapy on admission. We searched for differences between groups in terms of anamnestic, clinical and laboratory data and then in terms of COVID-19 outcomes.
Results: We found significant differences between groups in terms of age, comorbidities, procalcitonin and CPK serum levels: ST patients were older, more comorbid, with lower procalcitonin and higher CPK serum levels. Male sex was, together with the Charlson Comorbidity Index, an independent predictor of needing intensification of care, while age only was a good predictor of in-hospital and 100-day mortality. Differences were also found in the survival functions between the two groups.
Conclusions: After a period of observation of 100 days, ST patients, despite their older age and their greater load of comorbidities, have similar survival functions to NST patients. If adjusted for age and CCI the survival functions of ST group are considerably more favourable than those of the second group.
Keywords: COVID-19; HMG-CoA reductase inhibitor; SARS-CoV-2; Statins; Survival functions.
. 2021 Apr 27.
doi: 10.1007/s40292-021-00452-y. Online ahead of print.
Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy
Salvatore Greco[SUP] #[/SUP][SUP] 1 [/SUP], Andrea D'Amuri[SUP] #[/SUP][SUP] 1 [/SUP], Enrico Giorgini[SUP] 1 [/SUP], Francesco Luciani[SUP] 1 [/SUP], Mariarosaria Lopreiato[SUP] 1 [/SUP], Valeria Fortunato[SUP] 1 [/SUP], Alessandro Scopa[SUP] 1 [/SUP], Grazia Vestita[SUP] 1 [/SUP], Eleonora Capatti[SUP] 2 [/SUP], Angelina Passaro[SUP] 3 4 [/SUP]
Affiliations
- PMID: 33905094
- DOI: 10.1007/s40292-021-00452-y
Abstract
Introduction: The outbreak by SARS-CoV-2 has rapidly spread worldwide. The need for specific treatments to adequately stop the inflammatory response and its sequelae is day by day more urgent and many therapeutic strategies were performed since COVID-19 burst in the last months. Statins were thought to be effective against this novel coronavirus for their anti-inflammatory properties, even if the real effects on COVID patients are still partially unexplored.
Methods: We retrospectively evaluated 501 adult patients, consecutively admitted to the two COVID-hospitals of Ferrara's territory, and divided them into two groups: ST = patients on statin therapy on admission and NST=patients not on statin therapy on admission. We searched for differences between groups in terms of anamnestic, clinical and laboratory data and then in terms of COVID-19 outcomes.
Results: We found significant differences between groups in terms of age, comorbidities, procalcitonin and CPK serum levels: ST patients were older, more comorbid, with lower procalcitonin and higher CPK serum levels. Male sex was, together with the Charlson Comorbidity Index, an independent predictor of needing intensification of care, while age only was a good predictor of in-hospital and 100-day mortality. Differences were also found in the survival functions between the two groups.
Conclusions: After a period of observation of 100 days, ST patients, despite their older age and their greater load of comorbidities, have similar survival functions to NST patients. If adjusted for age and CCI the survival functions of ST group are considerably more favourable than those of the second group.
Keywords: COVID-19; HMG-CoA reductase inhibitor; SARS-CoV-2; Statins; Survival functions.